
Mastering Probability - New Trade Signals from this weekends scans as of April 23'rds close
This weekend’s scanner picked up the following signals for potential bottoms.
Stitch Fix has a weekly TD9 bottom as does the daily. The intraday charts show RMI bottoms.
Trade Setup |
ESTIMATED ENTRY PRICE |
INITIAL STOP |
TARGET EXIT |
CURRENT NEWSLETTER PRICE |
RISK % |
POSITION SIZE PER $10,000 |
CURRENT REWARD:RISK |
|||
|
||||||||||
BUY DATE |
SYMBOL |
DESCRIPTION |
|
|||||||
TBD |
SFIX |
STITCH FIX |
45.27 |
40.51 |
49.80 |
45.27 |
1.00% |
21 |
0.95 |
|
The trade setup looks like this and the initial price target is the top of its daily profile, but a move to its TD9 breakdown area is also a potential target.
Agile Therapeutics has a potential TD9 bottom for its weekly, an RMI and TD9 bottom for its daily and RMI signals for its intraday time frame.
Trade Setup |
ESTIMATED ENTRY PRICE |
INITIAL STOP |
TARGET EXIT |
CURRENT NEWSLETTER PRICE |
RISK % |
POSITION SIZE PER $10,000 |
CURRENT REWARD:RISK |
|||
|
||||||||||
BUY DATE |
SYMBOL |
DESCRIPTION |
|
|||||||
TBD |
AGRX |
AGILE THERAPEUTICS |
1.82 |
1.64 |
2.08 |
107.65 |
1.00% |
562 |
1.46 |
|
It’s trade setup looks like this.
Everquote has a potential weekly TD9 bottom while its daily chart shows a RMI bottom. The initial price target is the top of its profile, 35.77 and above that 42.17.
Trade Setup |
ESTIMATED ENTRY PRICE |
INITIAL STOP |
TARGET EXIT |
CURRENT NEWSLETTER PRICE |
RISK % |
POSITION SIZE PER $10,000 |
CURRENT REWARD:RISK |
|||
|
||||||||||
BUY DATE |
SYMBOL |
DESCRIPTION |
|
|||||||
TBD |
EVER |
EVERQUOTE |
33.60 |
31.08 |
35.77 |
33.60 |
1.00% |
40 |
0.86 |
|
It’s trade setup looks like this.
I will be reviewing more of the signal information generated by our scanner and send out an update should I see a worthwhile trade.
Combined Topping |
||||
Ticker |
Adj Score |
Total Score |
Last Price |
ATR |
LHX |
2.30 |
3.40 |
211.02 |
3.11 |
FXG |
2.18 |
2.90 |
58.74 |
0.56 |
GNTY |
2.00 |
3.00 |
39.64 |
1.01 |
IECS |
1.93 |
2.70 |
32.58 |
0.21 |
PBJ |
1.93 |
2.90 |
41.77 |
0.43 |
PSB |
1.88 |
2.50 |
163.84 |
3.03 |
JHMS |
1.85 |
2.60 |
34.72 |
0.24 |
KBR |
1.80 |
2.40 |
40.17 |
0.96 |
RHS |
1.78 |
2.70 |
161.10 |
1.43 |
SRDX |
1.78 |
2.70 |
58.20 |
1.99 |
UPS |
1.78 |
2.70 |
178.73 |
3.14 |
WM |
1.78 |
2.70 |
134.97 |
1.61 |
HSY |
1.75 |
2.80 |
161.43 |
2.22 |
CRAI |
1.68 |
2.90 |
77.00 |
3.01 |
EVBN |
1.65 |
2.20 |
35.32 |
1.07 |
IEDI |
1.65 |
2.20 |
43.93 |
0.39 |
KDP |
1.65 |
2.20 |
36.14 |
0.48 |
KXI |
1.65 |
2.20 |
60.15 |
0.44 |
MMC |
1.65 |
2.20 |
127.67 |
1.54 |
OTTR |
1.65 |
2.20 |
47.51 |
0.80 |
PSN |
1.65 |
2.20 |
42.69 |
0.81 |
Combined Bottoming |
||||
Ticker |
Adj Score |
Total Score |
Last Price |
ATR |
SFIX |
-2.08 |
-2.80 |
45.27 |
3.14 |
APRE |
-1.98 |
-2.70 |
4.65 |
0.36 |
SLNO |
-1.85 |
-2.70 |
1.19 |
0.09 |
GTT |
-1.80 |
-2.40 |
1.66 |
0.15 |
PTCT |
-1.80 |
-2.40 |
45.75 |
1.98 |
AGRX |
-1.78 |
-2.70 |
1.82 |
0.11 |
EVER |
-1.78 |
-2.70 |
33.60 |
1.59 |
EVFM |
-1.78 |
-2.70 |
1.50 |
0.15 |
FUSN |
-1.78 |
-3.70 |
8.49 |
0.66 |
GEO |
-1.73 |
-2.20 |
5.95 |
0.30 |
ASMB |
-1.65 |
-2.20 |
4.31 |
0.20 |
GLYC |
-1.65 |
-2.20 |
2.53 |
0.21 |
VVNT |
-1.65 |
-2.20 |
12.65 |
0.67 |
SPRO |
-1.58 |
-2.30 |
13.18 |
0.89 |
STOK |
-1.58 |
-2.10 |
31.58 |
2.53 |
ATNX |
-1.55 |
-2.40 |
4.03 |
0.27 |
CNST |
-1.55 |
-2.40 |
22.10 |
1.38 |
KPTI |
-1.55 |
-2.40 |
9.45 |
0.51 |
GRAY |
-1.53 |
-2.10 |
4.69 |
0.59 |
CRY |
-1.53 |
-1.90 |
22.93 |
0.64 |
Above are the top 20 top & bottom signals.
Disclaimer: Trading in securities such as stocks, options, indexes, currencies, and futures involve risk and should not be undertaken without due diligence and serious independent study. Options, stocks, currencies and futures trading, involve substantial risk. Subscribers may carry out their trading based on what they learn from “Mastering Probability” however all risks of potential financial losses are the customer’s responsibility. TFNN, Corp. and/or Steve Rhodes will be in no way liable for financial losses resulting from trading decisions based on this newsletter. Past performance is no guarantee of future results. Reproduction in whole, or in part, is not permitted without prior written consent. Copyright 2021 all rights reserved.